Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

DiaMedica Therapeutics (DMAC) Receivables: 2018

Historic Receivables for DiaMedica Therapeutics (DMAC) over the last 1 years, with Dec 2018 value amounting to $1.4 million.

  • DiaMedica Therapeutics' Receivables was N/A to $1.3 million in Q3 2019 from the same period last year, while for Sep 2019 it was $6.5 million, marking a year-over-year change of. This contributed to the annual value of $1.4 million for FY2018, which is N/A change from last year.
  • DiaMedica Therapeutics' Receivables amounted to $1.4 million in FY2018.
  • In the past 5 years, DiaMedica Therapeutics' Receivables ranged from a high of $1.4 million in FY2018 and a low of $1.4 million during FY2018.
  • In the last 1 years, DiaMedica Therapeutics' Receivables had a median value of $1.4 million in 2018 and averaged $1.4 million.